Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2012 Oct;36(10):1995-2002.
doi: 10.1007/s00264-012-1588-4. Epub 2012 Jun 12.

Aspirin for elective hip and knee arthroplasty: a multimodal thromboprophylaxis protocol

Affiliations

Aspirin for elective hip and knee arthroplasty: a multimodal thromboprophylaxis protocol

Ettore Vulcano et al. Int Orthop. 2012 Oct.

Abstract

Purpose: Multimodal thromboprophylaxis includes preoperative thromboembolic risk stratification and autologous blood donation, surgery performed under regional anaesthesia, postoperative rapid mobilisation, use of pneumatic compression devices and chemoprophylaxis tailored to the patient's individual risk. We determined the 90-day rate of venous thromboembolism (VTE), other complications and mortality in patients who underwent primary elective hip and knee replacement surgery with multimodal thromboprophylaxis.

Methods: A total of 1,568 consecutive patients undergoing hip and knee replacement surgery received multimodal thromboprophylaxis: 1,115 received aspirin, 426 received warfarin and 27 patients received low molecular weight heparin and warfarin with or without a vena cava filter.

Results: The rate of VTE, pulmonary embolism, proximal deep vein thrombosis (DVT) and distal DVT was 1.2, 0.36, 0.45 and 0.36 %, respectively, in patients who received aspirin. The rates in those who received warfarin were 1.4, 0.9, 0.47 and 0.47 %, respectively. The overall 90-day mortality rate was 0.2 %.

Conclusions: Multimodal thromboprophylaxis in which aspirin is administered to low-risk patients is safe and effective following primary total joint replacement.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Tree diagram illustrating VTE risk stratification process for the recommendation of chemoprophylaxis (all patients receive multimodal thromboprophylaxis)

References

    1. Freedman KB, Brookenthal KR, Fitzgerald RH, Jr, Williams S, Lonner JH. A meta-analysis of thromboembolic prophylaxis following elective total hip arthroplasty. J Bone Joint Surg. 2000;82:929–938. - PubMed
    1. Falck-Ytter Y, Francis CW, Johanson NA, et al. Prevention of VTE in orthopedic surgery patients: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest. 2012;141(2 Suppl):e278S–e325S. doi: 10.1378/chest.11-2404. - DOI - PMC - PubMed
    1. Treasure T, Chong LY, Sharpin C, Wonderling D, Head K, Hill J. Developing guidelines for venous thromboembolism for The National Institute for Clinical Excellence: involvement of the orthopaedic surgical panel. J Bone Joint Surg Br. 2010;92(5):611–616. doi: 10.1302/0301-620X.92B5.24448. - DOI - PubMed
    1. http://www.cms.hhs.gov/HospitalAcqCond/06_Hospital-Acquired_Conditions.asp
    1. Butt AJ, McCarthy T, Kelly IP, Glynn T, McCoy G. Sciatic nerve palsy secondary to postoperative haematoma in primary total hip replacement. J Bone Joint Surg Br. 2005;87:1465–1467. doi: 10.1302/0301-620X.87B11.16736. - DOI - PubMed

Publication types

MeSH terms